期刊文献+

动物用质粒DNA内毒素去除方法的建立及其质量检验 被引量:7

Establishment of endotoxin removal for animal-used plamsid and the quality detection
下载PDF
导出
摘要 用自行改进设计的TritonX-114方法去除动物用重组质粒DNA中的内毒素,鲎试剂检测方法确定每毫克质粒DNA中内毒素的含量为50 EU。将3种不同方法制备的重组质粒pEGFPN1包裹后转染COS-7、MDCK和Marc145细胞,结果表明,经TritonX-114去除内毒素后的质粒DNA(A)与无热源质粒提取试剂盒制备的质粒DNA(B)的转染效率相当,比未经内毒素去除的质粒DNA(C)的转染效率高。将上述3种方法制备的pcDNAlacZ经PEI包裹后尾静脉注射小鼠,注射后每隔2 d扑杀小鼠,取其心、肝、脾、肺和肾组织,定量检测β-半乳糖苷酶的表达和持续时间,结果显示报告基因仅在小鼠的心、脾和肝组织中表达至第8天,A与B的表达水平接近,且明显高于C制备的pcDNALacZ的表达水平,提示经TritonX-114去除内毒素后的质粒DNA可提高转染效率和表达水平。多种动物体内注射重组质粒后,无体温升高等异常临床表征,进一步说明了使用经TritonX-114去除内毒素的质粒DNA具备良好的安全性。 The endotoxin in animal-used plasmid was removed by self-designed TritonX-114 method, the endotoxin content was 50 endotoxin unit detected by Limulus amoebocyte lysate. Following coated with transfected reagent, the pEGFPN1 prepared by three ways was transfected into eukaryotie cell COS-7, MDCK and Marc-145. The fluorescence calculation results showed that the transfection efficiency of plasmid purified by the TritonX-114 (A) and EndoFree Plasmid Mega Kit (B)were similar,and the efficiency was higher than the plasmid without endotoxin removal(C), the pcDNAlacZ prepared as mentioned above was coated with PEI and injected into mice via tail vein, then the mice were killed every 2 days, the heart, liver, spleen, lung and kidney were sampled, and the β-glactosidase expression and persistence time were detected quantitatively. The results showed that the report gene was only expressed in the heart, spleen and liver in the recombinant plasmid injected-mice to 8 days, the expression level of A and B was similar,and was obvious higher than C,which indicated the plasmid with endotoxin removal by TritonX-114 could boost the transfection efficiency and expression level in vitro and vivo. The plasmid after endotoxin removal was injected into animals and no temperature and abnormality were observed, further explained the safety of the application of plasmid after purification with TritonX-114.
出处 《中国兽医学报》 CAS CSCD 北大核心 2009年第1期63-66,96,共5页 Chinese Journal of Veterinary Science
基金 国家863发展项目(2005AA246020)
关键词 TritonX-114 内毒素 转染效率 表达 安全性 TritonX-114 endotoxin transfection efficiency expression safety
  • 相关文献

参考文献17

  • 1Kowalczyk D W, Ertl H C. Immune response to DNA vaccines[J]. Cellular Molecular Life Sci, 1999,55 : 751- 770.
  • 2Martich G D,Boujoukos A J, Suffredini A F. Response of man to endotoxin[J]. Immunobiology, 1993,187 (3/ 5) :403-416.
  • 3Dagmar P, Friedrieh B A. Endotoxin removal from protein solutions[J]. J Biotechnol, 2000,76 (2/3):97- 119.
  • 4Judith H ,Warren H S. Antiendotoxin strategies[J]. Infect Dis Clin North Ameri,1999,13 (2):371-386.
  • 5Li L P, Luo R G. Quantitative determination of Ca2+ effects on endotoxin removal and protein yield in a two-stage ultrafilration process[J]. Sep Sci Technol, 1999,34 (9) :1729-1739.
  • 6Anspach FB, Hilbeck O. Removal of endotoxin by affinity sorbents[J]. J chromatography A, 1995, 711 (1):81-92.
  • 7Minbo S,Watanabe T,Sato T,et al. Preparation of adsorbents for pyrogen adsorption[J]. J Chromatography, 1983,248: 193-203.
  • 8Phillip M M, Robert W M. Improved method for the removal of endotoxin from DNA[J]. J of Biotechnol, 1996,44 (1/3):43-46.
  • 9Mitzner S, Schneidewind J, Falkenhagen D, et al. Extra corporeal endotoxin removal by immobilized polyethylenimine[J]. Artifical Organs, 1993,17 (9) : 775-781.
  • 10Hirayama C, Sakata M, Nakamura M, et al. Prepara tion of poly (Epsilon-lysine) adsorbents and application to selective removal of lipopolysaecharide[J]. J chromatography B, 1999,721 : 187-195.

二级参考文献9

  • 1MacGregor RR, Boyer JD, Ugen KE et al. First human trial of a DNA- based vaccine for.treatment of human immunodeficiency virus type Ⅰ infection:safety and host response. J Infect Dis,1998,178(1):92.
  • 2Roy MJ, Wu MS, Barr LJ et al. Induction of antigen-specific CD8^+ T helper cells, and protective levels of antibody in humans by particle-mediated administration of hepatitis B virus DNA vaccine, Vaccine, 2001(7--8),19:764.
  • 3Wang R,Doolan DL, Le TP et al. Induction of antigen-specific cytoxic T lymphocytes in humans by a malaria DNA vaccine. Science, 1998,282(5388): 476.
  • 4Parker SE, Borellini F, Wenk ML et al. Plasmid DNA malaria vaccine:Tissue distribution and safety studies in mice and rabbits. Hum Gene Ther, 1999,10(5) : 741.
  • 5Parker SE, Monteith D, Horton Het al. Safety of a GM-CSF adjuvantplasmid DNA malaria vaccine. Gene Ther, 2001,8(13):1011.
  • 6Danko I, Wolff JA. Direct gene transfer into muscle. Vaccine, 1994, 12(16):1499.
  • 7Chow YH, Chiang BL, Lee YL et al. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can he modulated by co-delivery of various cytokine genes. J Immunol, 1998,160(3): 1320.
  • 8(美)J.萨姆布鲁克(J.Sambrook)等著,金冬雁等.分子克隆实验指南[M]科学出版社,1992.
  • 9杨富强,陈光明,何晓嫱,李治刚,吴乐园,黄英.DNA疫苗诱导健康小鼠细胞免疫及HBV转基因小鼠抗-HBs产生[J].中国免疫学杂志,2002,18(6):376-379. 被引量:3

共引文献7

同被引文献56

引证文献7

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部